Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Merck & Co. Stock: Is MRK Underperforming the Healthcare Sector?

Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a leading global healthcare company with a market cap of $300.01 billion. Renowned for its innovative pharmaceuticals, vaccines, and animal health products, MRK plays a crucial role in advancing medical research and improving patient care worldwide. Competing intensely with other pharmaceutical powerhouses, Merck's main rivals include Pfizer Inc. (PFE), which is distinguished for its pioneering medical treatments and vaccine developments. 

Companies worth $200 billion or more are generally described as "mega-cap stocks," and Merck definitely fits that description. A long-standing leader in the pharmaceutical industry, Merck has established a significant presence in the global healthcare market and is known for its innovative research and development of vaccines and medicines. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.